SREBF2 and urinary bladder cancer: These results suggested that FXR overexpression may decrease cholesterol synthesis in human TSGH8301 and T24 bladder cancer cells by reducing SREBP2, HMGCR, and PI3KAKT/mTOR signaling and enhancing AMPK phosphorylation.